Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation
A completed clinical trial evaluating the pharmacokinetic characteristics of intravenous Hepabig injection used to prevent hepatitis B relap…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Validation of BIVA for Nutritional Assessment in Cirrhotic Patients
A completed clinical trial validating the use of Bioelectrical Impedance Vector Analysis (BIVA) for nutritional assessment in patients with …
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis [Phase 2]
Phase 2 trial of bosentan for hepatopulmonary syndrome in patients with liver cirrhosis has been terminated.
-
FDA approval · 2016-09-19FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)
FDA approved a supplemental application for furosemide submitted by Phlow Corporation.
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Transitional Care Interventions for Patients With Cirrhosis Post-TIPS [NA]
Clinical trial update on transitional care interventions for patients with liver cirrhosis after TIPS.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis [Phase 4]
Phase 4 trial update evaluating MRI with gadoxetic acid for non-invasive diagnosis of hepatocellular carcinoma in patients with liver cirrho…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment [Phase 2]
A Phase 2 trial evaluating midodrine plus albumin for cirrhosis with functional renal impairment has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation [Phase 4]
A Phase 4 clinical trial evaluated midodrine plus albumin to prevent complications in patients with liver cirrhosis awaiting transplantation…
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: Microparticles in Cirrhosis and Portal Hypertension [NA]
This entry provides an update on a clinical trial investigating microparticles in liver cirrhosis and portal hypertension. The study is mark…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV [Phase 3]
Phase 3 trial update evaluating transjugular intrahepatic portosystemic shunt (TIPS) to prevent variceal rebleeding in cirrhotic patients wi…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis [Phase 2]
Phase 2 study evaluating ritonavir-boosted danoprevir with RO5024048 in null responders or treatment-naïve chronic hepatitis C patients with…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation [NA]
This document reports a completed clinical trial evaluating the administration of probiotics in patients with liver cirrhosis who are listed…
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population. [NA]
This update describes a clinical trial evaluating a three-biomarker approach developed by WAKO to enable early diagnosis of hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection [Phase 3]
Phase 3 trial in cirrhotic adults with genotype 1b chronic hepatitis C infection has completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? [NA]
A completed clinical trial from University of Sao Paulo General Hospital compares surgical versus conservative treatment for abdominal herni…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy [NA]
A clinical trial evaluating fructans, lactitol, and lactose for minimal hepatic encephalopathy in patients with liver cirrhosis has complete…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Renal Function Determination in Patients With Liver Cirrhosis
This clinical trial update notes that the study evaluating renal function determination in patients with liver cirrhosis has completed.
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis [Phase 1, Phase 2]
This entry reports an ongoing Phase 1/Phase 2 clinical trial evaluating mesenchymal stem cell transplantation for liver cirrhosis caused by …
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) [Phase 3]
The Phase 3 CATS trial evaluating satavaptan for ascites due to liver cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver [Phase 3]
Phase 3 trial of satavaptan to prevent recurrence of ascites in patients with cirrhosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver [Phase 3]
A Phase 3 trial of satavaptan for preventing recurrence of ascites in patients with ascites due to liver cirrhosis was terminated.
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers [NA]
An update on a clinical trial evaluating Fibroscan to assess liver fibrosis in patients with cardiac pacemakers; current status is not discl…
-
CLINICAL_TRIALS research · 2016-05-02Clinical Trial Update: The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter [NA]
A multicenter clinical trial is establishing a genetic network-based model to predict tacrolimus metabolism after liver transplantation; the…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF [Phase 2]
Phase 2 pharmacokinetic and pharmacodynamic study of IDN-6556 in acute liver failure conditions was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation [Phase 1]
Phase 1 safety study of liver natural killer (NK) cell therapy in patients undergoing liver transplantation for hepatocellular carcinoma; re…